CGI presented its work on how pathogenic variant classifications are not always well-supported by evidence. Working together with genetic counselors from Rocky Mountain Cancer Centers and Texas Oncology, CGI collected de-identified patient reports and examined the...
At the National Society of Genetic Counselors Annual Education Conference, CGI presented a poster on “Calculating and Communicating Error Estimates for Pathogenic Variant Classifications in Germline Sequence Tests.” The poster focused on CGI’s creation of a Positive...
Dr. Julie Eggington, Co-founder and CGI CEO, was asked by the press to comment on the outcomes of the Williams v Quest/Athena variant classification lawsuit: “Experts acknowledged…that variant classification remains a growing source of lab liability that the...
Recent Comments